You are here

AusPAR: Mepolizumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

5 March 2020
AusPAR Details
AusPAR
Active Ingredient
Mepolizumab
Product Name
Nucala
Sponsor
GlaxoSmithKline Australia Pty Ltd
Submission Number
PM-2018-00537-1-5
Submission Type
Extension of indications
Decision
Rejected
AusPAR Date
18 February 2020
Publication Date

5 March 2020